AI assistant
DEXCOM INC — Director's Dealing 2018
Jun 5, 2018
30198_dirs_2018-06-04_5e2d7c43-ad81-449e-816e-ce755472c642.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2018-05-31
Reporting Person: TOPOL ERIC (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-05-31 | Common Stock | A | 3695 | $0.001 | Acquired | 8348 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 99909 | Indirect |
Footnotes
F1: Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. commom stock upon settlement.
F2: The RSU Award was granted on May 31, 2018 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2019 Annual Meeting.
F3: Represents 8,348 restricted stock units, 4,653 of which were granted on June 1, 2017 and shall vest on June 1, 2018 and 3,695 of which were granted on May 31, 2018 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2019 Annual Meeting.